FIELD: medicine, pulmonology. SUBSTANCE: invention proposes the use of perfluorane as an agent for treatment of patients with chemical damages of lung. Agent enhances viability, relieves the course of intoxication and decreases hydration of pulmonary tissue by 2-fold. EFFECT: enhanced effectiveness of agent. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF HYPOXIA | 2003 |
|
RU2262343C2 |
ANTIDOTE FOR CARBON MONOXIDE AND HEPATOTOXIC SUBSTANCES | 2015 |
|
RU2584586C1 |
ANTIDOTE FOR CARBON MONOXIDE | 2015 |
|
RU2581467C1 |
APPLICATION OF HYDROCHLORIDE N,N-DIETHYL-5,5-DIPHENYL-2-PENTINYLAMINE FOR TREATING NON-CARDIOGENIC PULMONARY OEDEMA | 2020 |
|
RU2762495C1 |
ANTIDOTE OF BIOLOGICAL SNAKE VENOMS | 1999 |
|
RU2185850C2 |
METHOD FOR SIMULATING COMBINED EXPOSURE TO DEPLETED URANIUM | 2014 |
|
RU2561295C1 |
METHOD FOR PREDICTING THE RESULT OF ACUTE INTOXICATIONS BY NEUROTROPIC POISONS ACCORDING TO THE DISORDERS OF PULMONARY GASEOUS EXCHANGE | 2000 |
|
RU2195859C2 |
ANTIHYPOXYC AGENT FOR TREATING REMOTE CONSEQUENCES OF METHEMOGLOBIN FORMER POISONINGS | 2008 |
|
RU2392958C2 |
METHOD FOR PREVENTING ANIMAL INTOXICATION ACCOMPANYING ACUTE POISONING WITH HYDROGEN SULPHIDE-CONTAINING GAS IN EXPERIMENT | 2019 |
|
RU2739256C1 |
SOLUTION FOR MAKING INJECTIONS | 2004 |
|
RU2276978C2 |
Authors
Dates
2001-06-27—Published
1999-05-17—Filed